acut
respiratori
tract
infect
import
sourc
morbid
mortal
loss
workforc
day
throughout
world
patient
extrem
age
preexist
cardiopulmonari
diseas
immun
suppress
particular
risk
despit
advanc
understand
microbi
pathogen
develop
new
antimicrobi
agent
acut
respiratori
tract
infect
continu
place
enorm
burden
global
health
expenditur
broadli
speak
acut
respiratori
tract
infect
divid
infect
predominantli
affect
upper
respiratori
tract
lower
respiratori
tract
anatom
vocal
cord
serv
divid
line
two
area
upper
respiratori
tract
nasopharynx
peritonsillar
structur
sinus
larynx
epiglotti
proxim
cord
lower
upper
respiratori
tract
bronchial
tree
pulmonari
parenchyma
cord
unlik
vital
organ
lung
expos
daili
larg
amount
pathogen
present
air
potenti
vulner
infect
inflamm
optim
ga
exchang
respiratori
tract
vast
surfac
area
thin
delic
epithelium
extens
blood
flow
inher
structur
enorm
immunolog
burden
liter
air
inhal
daili
contain
myriad
pathogen
pollut
allergen
normal
lung
mani
inhal
microb
trap
mucu
layer
coat
nasal
epithelium
upper
respiratori
tract
trap
transport
ciliari
motion
pharynx
swallow
organ
evad
mucociliari
clearanc
protect
innat
immun
mechan
act
local
facilit
clearanc
inhal
pathogen
modul
inflammatori
respons
howev
respiratori
tract
defens
breech
infect
occur
sometim
devast
consequ
host
acut
upper
respiratori
tract
infect
utri
predominantli
viral
natur
repres
common
respiratori
complaint
account
famili
practic
consult
unit
kingdom
common
categori
infecti
diseas
unit
state
major
urti
mild
selflimit
small
number
give
rise
seriou
problem
notabl
acut
epiglotti
medic
emerg
children
influenza
elderli
patient
debilit
ill
although
virus
common
pathogen
implic
physician
must
alert
possibl
primari
bacteri
pathogen
perhap
bacteri
superinfect
follow
initi
viral
ill
high
fever
promin
constitut
symptom
prolong
ill
import
pointer
toward
bacteri
etiolog
necessit
antimicrobi
therapi
common
urti
describ
follow
paragraph
common
cold
symptom
complex
character
nasal
congest
sneez
rhinorrhoea
pharyng
cough
differ
viral
agent
includ
coronavirus
respiratori
syncyti
virus
parainfluenza
influenza
virus
known
caus
coryza
although
rhinoviru
common
etiolog
agent
transmiss
handnosehand
inocul
droplet
spread
incub
period
typic
hour
ill
may
last
week
patient
persist
week
immun
shortliv
virusspecif
adult
suffer
coryz
ill
annual
children
tend
frequent
cold
per
year
cigarett
smoker
also
frequent
viral
urti
physic
find
gener
confin
upper
respiratori
tract
includ
nasal
mucos
edema
pharyng
erythema
therapi
princip
support
includ
bed
rest
paracetamol
g
hourli
system
symptom
fever
nasal
decongest
case
benefit
vitamin
c
therapi
remain
unproven
dougla
et
al
sasazuki
et
al
similarli
data
support
wide
use
plant
extract
echinacea
coryza
lack
lind
et
al
complic
coryza
predominantli
due
secondari
bacteri
infect
sinus
case
otiti
media
case
bronchiti
pneumonia
pharyng
may
occur
part
common
cold
separ
ill
etiolog
agent
includ
virus
also
bacteria
group
beta
hemolyt
streptococci
mycoplasma
pneumonia
chlamydia
pneumonia
patient
present
sore
throat
erythema
pharynx
often
accompani
tonsillar
enlarg
epsteinbarr
viru
often
affect
pharynx
infecti
mononucleosi
may
associ
lymphadenopathi
splenomegali
blood
film
demonstr
atyp
monocyt
posit
heterophil
antibodi
test
streptococc
pharyng
may
complic
glomerulonephr
rare
rheumat
fever
recent
advanc
rapid
streptococc
antigen
test
throat
cultur
reserv
patient
symptom
improv
time
respond
antibiot
vincent
et
al
antibiot
treatment
oral
penicillin
may
reduc
durat
ill
prevent
suppur
complic
pharyng
abscess
infect
sinus
caus
nasal
congest
purul
nasal
discharg
maxillari
tooth
discomfort
hyposmia
facial
pain
pressur
wors
bend
forward
varieti
organ
may
caus
acut
sinus
includ
virus
adult
haemophilu
influenza
morexalla
catarrhali
streptococcu
pneumonia
account
acut
bacteri
sinus
anaerob
bacteria
also
implic
acut
sinus
gener
treat
day
oral
antimicrobi
therapi
adjunct
treatment
form
nasal
decongest
simpl
analgesia
therapi
base
knowledg
local
pattern
antibiot
resist
spectrum
activ
common
pathogen
includ
resist
penicillin
macrolid
pharmacodynam
potenc
benning
et
al
complic
acut
sinus
includ
facial
cellul
osteomyel
intracrani
abscess
format
mening
cavern
sinu
thrombosi
acut
swell
inflamm
epiglotti
aryepiglott
fold
lifethreaten
condit
usual
caus
virul
strain
haemophilu
influenza
type
b
death
may
occur
upper
airway
occlus
asphyxi
common
children
age
year
also
occur
adult
ill
usual
start
fever
sore
throat
progress
rapidli
voic
chang
drool
stridor
respiratori
distress
presenc
stridor
voic
muffl
rapid
clinic
cours
underli
diabet
mellitu
shown
correl
need
airway
intervent
katori
tsukuda
direct
visual
epiglotti
may
reveal
edemat
erythemat
epiglotti
project
back
tongu
laryngoscop
blade
examin
avoid
risk
precipit
total
airway
obstruct
later
cervic
xray
may
show
epiglott
swell
thumbprint
sign
blood
cultur
follow
prompt
antibiot
therapi
ampicillin
chloramphenicol
thirdgener
cephalosporin
skill
invas
airway
manag
cornerston
treatment
orotrach
nasal
tracheal
intub
usual
done
gener
anesthesia
proceed
tracheostomi
tracheal
intub
possibl
role
corticosteroid
manag
acut
epiglott
establish
croup
acut
laryngotracheobronch
usual
caus
virus
respiratori
syncyti
viru
influenza
b
rhinovirus
adenoviru
measl
commonli
occur
month
year
age
peak
incid
second
year
life
patient
usual
present
bark
cough
dyspnea
follow
upper
respiratori
tract
infect
support
treatment
inhal
steam
wide
use
despit
littl
evid
scolnik
et
al
system
corticosteroid
reduc
sever
croup
dramat
reduc
need
endotrach
intub
reduc
need
hospit
admiss
subsequ
length
hospit
stay
reduc
durat
ill
fitzgerald
influenza
acut
system
viral
ill
character
pyrexia
malais
myalgia
headach
nasal
congest
harsh
unproduct
cough
may
last
sever
day
caus
group
rna
myxovirus
commonli
type
b
capabl
undergo
frequent
spontan
chang
hemagglutinin
neuraminidas
surfac
antigen
refer
antigen
drift
associ
minor
outbreak
antigen
shift
associ
epidem
pandem
incub
period
day
viral
spread
via
aerosol
mucos
contact
infect
secret
morbid
mortal
signific
particularli
extrem
age
underli
cardiorespiratori
diseas
viral
impair
mucociliari
clearanc
macrophag
function
promot
secondari
bacteri
infect
result
pneumonia
bronchiti
otiti
media
caus
organ
staphylococcu
aureu
streptococcu
peumonia
haemophilu
influenza
therapi
mainli
symptomat
antipyret
bed
rest
fluid
amantadin
may
amelior
symptom
influenza
given
within
first
h
may
also
use
prophylact
highrisk
individu
epidem
howev
resist
agent
emerg
bright
et
al
annual
vaccin
recommend
underli
cardiopulmonari
diseas
renal
failur
diabet
elderli
popul
live
nurs
home
acut
lower
respiratori
tract
infect
lrti
divid
affect
airway
give
rise
bronchiti
give
rise
pulmonari
parenchym
inflamm
form
pneumonia
upper
respiratori
tract
viral
bacteri
pathogen
implic
lrti
rang
sever
mild
shortliv
episod
otherwis
healthi
person
sever
lifethreaten
ill
acut
bronchiti
inflamm
larg
conduct
airway
one
common
diagnos
made
primari
care
clinician
emerg
depart
physician
cough
without
purul
sputum
associ
urti
symptom
suggest
diagnosi
acut
bronchiti
otherwis
healthi
patient
bronchiti
may
present
manner
similar
pneumonia
differ
absenc
sign
consolid
chest
examin
absent
chest
xray
find
respiratori
virus
appear
common
caus
acut
bronchiti
howev
organ
respons
rare
identifi
clinic
practic
viral
cultur
serolog
assay
routin
perform
influenza
b
coronaviru
rhinoviru
herp
simplex
parainfluenza
respiratori
syncyti
viru
implic
acut
bronchiti
selflimit
respiratori
disord
cough
persist
week
diagnos
must
consid
presenc
underli
chronic
pulmonari
diseas
manifest
etiolog
agent
differ
consider
seen
normal
host
bacteri
etiolog
includ
h
influenza
pneumococcu
pneumonia
b
catarrhali
b
catarrhali
bronchiti
associ
impair
host
defens
commonli
seen
cigarett
smoker
preexist
cardiopulmonari
diseas
prolong
highgrad
fever
unusu
uncompl
bronchial
infect
substern
burn
discomfort
may
present
togeth
wheez
rhonci
larg
airway
irrit
recurr
bout
acut
bronchiti
children
prompt
consider
underli
immun
disord
respiratori
disord
cystic
fibrosi
support
therapi
analgesia
antipyret
adequ
hydrat
assist
expector
viscid
secret
may
requir
antimicrobi
treatment
acut
bronchiti
controversi
benefit
treatment
margin
mani
studi
perhap
viral
natur
mani
case
howev
recent
guidelin
american
colleg
chest
physician
suggest
widespread
use
antibiot
treatment
acut
bronchiti
justifi
effort
curtail
use
encourag
braman
pneumonia
may
defin
inflamm
substanc
lung
term
gener
impli
parenchym
inflamm
caus
infect
global
estim
million
children
age
year
die
pneumonia
year
develop
countri
approxim
million
case
communityacquir
pneumonia
cap
annual
unit
state
requir
hospit
admiss
pneumonia
sixth
lead
caus
death
unit
state
common
caus
death
infecti
diseas
unit
kingdom
incid
case
per
popul
per
year
case
per
requir
hospit
admiss
approxim
case
requir
intens
care
admiss
admiss
rate
higher
elderli
per
case
death
elderli
relat
pneumonia
although
often
termin
ill
patient
seriou
concomit
diseas
outpati
set
mortal
rate
pneumonia
remain
low
rang
less
patient
requir
hospit
mortal
rate
approach
overal
increas
specif
popul
bacteremia
nurs
home
set
pneumonia
necessit
intens
care
admiss
mortal
rate
approach
overal
pneumonia
classifi
accord
site
affect
local
affect
one
lobe
segment
lobar
diffus
affect
lobul
bronchi
bronchiol
bronchopneumonia
gener
term
lobar
pneumonia
seen
previous
healthi
peopl
bronchopneumonia
common
elderli
underli
lung
diseas
pneumonia
also
classifi
accord
etiolog
exampl
bacteri
viral
fungal
atyp
chemic
radiat
allerg
classif
widespread
clinic
use
base
origin
sourc
infect
cap
defin
acut
pulmonari
parenchym
infect
person
hospit
preced
day
resid
nurs
home
longterm
care
facil
hospitalacquir
nosocomi
pneumonia
defin
pneumonia
occur
hour
hospit
admiss
estim
occur
patient
admit
hospit
carri
mortal
rate
approach
patient
intens
care
set
develop
pneumonia
ventil
form
pneumonia
refer
ventilatorassoci
pneumonia
vap
spectra
caus
organ
cap
nosocomi
pneumonia
shown
tabl
patient
pneumonia
may
present
constel
symptom
sign
fever
hypothermia
present
case
symptom
includ
rigor
pleurit
pain
new
cough
without
purul
sputum
examin
may
reveal
auscultatori
crackl
sign
consolid
tachypnea
tachycardia
symptom
sign
may
mask
absent
elderli
initi
approach
patient
pneumonia
includ
assess
sever
need
hospit
identif
like
pathogen
institut
empir
antibiot
therapi
specif
clue
like
etiolog
often
obtain
histori
physic
examin
summar
tabl
patient
mild
pneumonia
usual
treat
outpati
set
requir
less
investig
sever
pneumonia
main
object
investig
patient
clinic
diagnosi
pneumonia
obtain
radiolog
confirm
diagnosi
exclud
condit
mimic
pneumonia
obtain
microbiolog
diagnosi
assess
sever
pneumonia
identifi
develop
complic
investig
includ
follow
chest
xray
confirm
diagnosi
demonstr
area
consolid
may
help
detect
complic
lung
abscess
parapneumon
effus
exampl
chest
xray
chang
pneumonia
shown
figur
sputum
gram
stain
cultur
may
help
identifi
caus
organ
prior
antibiot
therapi
contamin
oropharyng
flora
may
limit
use
blood
cultur
perform
case
pneumonia
necessit
hospit
admiss
posit
case
pneumococc
pneumonia
case
pneumonia
serolog
test
may
allow
retrospect
diagnosi
infect
organ
rise
titer
found
acut
convalesc
sampl
use
certain
virus
atyp
pneumonia
organ
mycoplasma
pneumonia
sever
cap
consid
pneumonia
requir
intens
care
unit
icu
admiss
howev
gener
accept
definit
sever
pneumonia
avail
criteria
icu
admiss
remain
undetermin
case
must
assess
individu
british
thorac
societi
bt
criteria
sever
pneumonia
includ
two
follow
clinic
sign
laboratori
data
hypotens
systol
blood
pressur
mmhg
diastol
blood
pressur
mmhg
tachypnea
respiratori
rate
breathsmin
confus
disorient
laboratori
indic
indic
sever
infect
includ
leukopenia
leukocytosi
wcc
l
l
rais
blood
urea
mmoll
acidosi
ph
hypoxia
pao
kpa
poor
prognost
includ
age
greater
signific
comorbid
eg
diabet
congest
cardiac
failur
ccf
copd
immunocompromis
malign
chronic
renal
failur
malnutrit
alcohol
cerebrovascular
accid
patient
hospit
within
previou
year
extrapulmonari
site
infect
also
risk
poorer
outcom
anem
patient
hemoglobin
gmdl
evid
sepsi
organ
dysfunct
manifest
metabol
acidosi
coagulopathi
less
favor
outcom
admiss
icu
often
requir
mechan
ventil
inotrop
support
either
admiss
follow
failur
improv
clinic
deterior
convent
therapi
use
noninvas
ventil
particularli
pneumonia
occur
copd
popul
may
support
patient
suffici
avoid
icu
admiss
american
thorac
societi
at
guidelin
admiss
icu
includ
either
follow
two
major
criteria
need
mechan
ventil
presenc
septic
shock
two
three
follow
minor
criteria
multilobar
diseas
pao
fio
ratio
less
systol
blood
pressur
less
mmhg
guidelin
at
european
respiratori
societi
er
bt
recommend
empir
treatment
pneumonia
base
like
pathogen
popul
treat
possibl
atyp
infect
macrolid
alon
outpati
set
intraven
macrolid
hospit
patient
risk
factor
drugresist
strep
pneumonia
drsp
gramneg
aspir
outpati
nonicu
inpati
risk
factor
treat
betalactam
macrolid
combin
fluoroquinolon
alon
regimen
therapeut
equival
outpati
treatment
complic
patient
fluoroquinolon
monotherapi
may
conveni
betalactammacrolid
combin
icu
patient
treat
betalactam
macrolid
quinolon
use
two
antipseudomona
agent
atrisk
patient
acut
upper
lower
respiratori
tract
infect
common
caus
morbid
mortal
worldwid
chapter
review
variou
clinic
present
diagnost
approach
like
etiolog
agent
therapeut
consider
patient
present
acut
respiratori
tract
infect
emerg
antimicrobi
resist
among
mani
respiratori
viral
bacteri
pathogen
acut
infect
respiratori
tract
like
continu
pose
signific
global
health
burden
futur
judici
appropri
use
antibiot
togeth
research
improv
understand
microbi
pathogen
resist
may
help
combat
infect
reduc
unfavor
outcom
respiratori
syncyti
viru
rsv
import
caus
acut
lower
respiratori
tract
infect
young
children
worldwid
gener
around
quarter
childhood
admiss
hospit
acut
respiratori
infect
due
rsv
sever
infect
common
first
year
life
rsv
caus
characterist
diseas
entiti
call
bronchiol
rsv
identifi
first
group
chimpanze
accordingli
call
chimpanze
coryza
agent
cca
later
document
mainli
human
pathogen
